EA202090666A1 - Применение содержащей бензоат композиции для лечения глициновой энцефалопатии - Google Patents
Применение содержащей бензоат композиции для лечения глициновой энцефалопатииInfo
- Publication number
- EA202090666A1 EA202090666A1 EA202090666A EA202090666A EA202090666A1 EA 202090666 A1 EA202090666 A1 EA 202090666A1 EA 202090666 A EA202090666 A EA 202090666A EA 202090666 A EA202090666 A EA 202090666A EA 202090666 A1 EA202090666 A1 EA 202090666A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- benzoate
- treatment
- application
- containing composition
- glycine encephalopathy
- Prior art date
Links
- 208000035544 Nonketotic hyperglycinaemia Diseases 0.000 title abstract 2
- 201000011205 glycine encephalopathy Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- ITRIWXSLDIKBHK-UHFFFAOYSA-N (3-benzoyloxy-2-hydroxypropyl) benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC(O)COC(=O)C1=CC=CC=C1 ITRIWXSLDIKBHK-UHFFFAOYSA-N 0.000 abstract 1
- HIZCTWCPHWUPFU-UHFFFAOYSA-N Glycerol tribenzoate Chemical compound C=1C=CC=CC=1C(=O)OCC(OC(=O)C=1C=CC=CC=1)COC(=O)C1=CC=CC=C1 HIZCTWCPHWUPFU-UHFFFAOYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762569251P | 2017-10-06 | 2017-10-06 | |
| PCT/US2018/052879 WO2019070478A1 (en) | 2017-10-06 | 2018-09-26 | USE OF A BENZOATE-CONTAINING COMPOSITION FOR TREATING GLYCINIC ENCEPHALOPATHY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202090666A1 true EA202090666A1 (ru) | 2020-08-05 |
Family
ID=65994915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202090666A EA202090666A1 (ru) | 2017-10-06 | 2018-09-26 | Применение содержащей бензоат композиции для лечения глициновой энцефалопатии |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11304923B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3691630A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2020536098A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200065012A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111212637A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2018345244A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020005856A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3078609A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202090666A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019070478A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020176432A1 (en) * | 2019-02-25 | 2020-09-03 | Rush University Medical Center | Compositions including cinnamic acid and methods of use thereof |
| EP3999051B1 (en) * | 2019-07-16 | 2025-07-09 | Rush University Medical Center | Inhalation dosage forms of glycerol tribenzoate and/or glycerol dibenzoate for use in the treatment of huntington's disease |
| CA3205005A1 (en) * | 2020-12-16 | 2022-06-23 | Rush University Medical Center | Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2811991A4 (en) * | 2012-02-10 | 2016-03-16 | Whitehead Biomedical Inst | INHIBITION OF THE GLYCIN CLEAVAGE SYSTEM FOR THE TREATMENT OF CANCER |
| PT3094616T (pt) * | 2014-01-17 | 2021-03-03 | Univ Rush Medical Center | O uso de uma composição que contém tribenzoato de glicerilo em distúrbios neurodegenerativos |
-
2018
- 2018-09-26 US US16/648,422 patent/US11304923B2/en active Active
- 2018-09-26 BR BR112020005856-4A patent/BR112020005856A2/pt not_active IP Right Cessation
- 2018-09-26 EA EA202090666A patent/EA202090666A1/ru unknown
- 2018-09-26 WO PCT/US2018/052879 patent/WO2019070478A1/en not_active Ceased
- 2018-09-26 CA CA3078609A patent/CA3078609A1/en active Pending
- 2018-09-26 JP JP2020519254A patent/JP2020536098A/ja active Pending
- 2018-09-26 KR KR1020207011606A patent/KR20200065012A/ko not_active Ceased
- 2018-09-26 CN CN201880063022.9A patent/CN111212637A/zh active Pending
- 2018-09-26 AU AU2018345244A patent/AU2018345244A1/en not_active Abandoned
- 2018-09-26 EP EP18865150.9A patent/EP3691630A4/en active Pending
-
2022
- 2022-01-17 AU AU2022200277A patent/AU2022200277A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3691630A1 (en) | 2020-08-12 |
| CN111212637A (zh) | 2020-05-29 |
| KR20200065012A (ko) | 2020-06-08 |
| BR112020005856A2 (pt) | 2020-09-29 |
| US11304923B2 (en) | 2022-04-19 |
| AU2022200277A1 (en) | 2022-02-03 |
| WO2019070478A1 (en) | 2019-04-11 |
| JP2020536098A (ja) | 2020-12-10 |
| US20200281884A1 (en) | 2020-09-10 |
| EP3691630A4 (en) | 2021-10-27 |
| AU2018345244A1 (en) | 2020-04-02 |
| CA3078609A1 (en) | 2019-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201892395A1 (ru) | Лекарственные составы ингибитора lsd1 | |
| CY1122792T1 (el) | Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου δαγκειου ιου | |
| EA202090573A1 (ru) | Составы нирапариба | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| BR112015022096A8 (pt) | compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos | |
| JOP20180025A1 (ar) | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك | |
| EA201891063A1 (ru) | Производные дигидроимидазопиразинона, применимые в лечении рака | |
| EA201991387A1 (ru) | ТРИЦИКЛИЧЕСКИЕ ЕНОНЫ - ПРОИЗВОДНЫЕ ПИРИМИДИНА ДЛЯ ИНГИБИРОВАНИЯ ROR-γ И ДРУГИХ ПРИМЕНЕНИЙ | |
| EA202090448A1 (ru) | Дигидрооксадиазиноны | |
| BR112019024747A2 (pt) | formulações de dose fixa | |
| EA202192905A1 (ru) | Соединения, содержащие n-метил-2-пиридон, и фармацевтически приемлемые соли | |
| EA202190960A1 (ru) | Конденсированные пирролины, которые действуют как ингибиторы убиквитин-специфической протеазы 30 (usp30) | |
| EA202190588A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| EA202090098A1 (ru) | Фармацевтические композиции терапевтически активных соединений | |
| EA201992116A1 (ru) | Фармацевтические составы флороглюцинола и триметилфлороглюцинола | |
| MX340985B (es) | Compuestos de n-heteroarilo. | |
| BR112018005905A2 (pt) | ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto? | |
| EA201790949A1 (ru) | Замещенные 2,4-диаминохинолины в качестве новых противораковых средств | |
| BR112015019412A2 (pt) | inibidores de bace1 | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA202191478A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
| EA201991951A1 (ru) | Низковязкие высококонцентрированные составы на основе эволокумаба и способы их получения | |
| EA202192199A1 (ru) | Композиции, содержащие коричную кислоту, и способы их применения | |
| EA202191955A1 (ru) | Таблетированные составы с модифицированным высвобождением, содержащие ингибиторы фосфодиэстеразы |